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Distinct HLA class II alleles influence antibody
response to the Plasmodium vivax Duffy binding
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Plasmodium vivax infects human reticulocytes through a
major pathway that requires interaction between an apical
parasite protein, the Duffy binding protein (region II,
DBPII) and its cognate receptor on reticulocytes, the Duffy
antigen receptor for chemokines (DARC). Although most
people naturally exposed to P. vivax fail to develop antibo-
dies that inhibit the DBPII-DARC interaction, the genetic
factors that modulate humoral responsiveness are poorly
characterized. Aiming to investigate if DBPII non-respon-
siveness could be HLA class II-linked (DRB1, DQB1 and
DQA1), we carried-out an open cohort study among 340
non-related volunteers in an agricultural settlement of the
Brazilian Amazon; three cross-sectional surveys were con-
ducted at 6-month intervals, and 240 out of 340 (71%)
subjects had consecutive samples. At enrolment, 40.9% of
the study population had DBPII IgG antibodies, as mea-
sured by conventional serology (ELISA); two alleles at
HLA-DR locus (DRB1*10:01 and DRB1*14:02) were nega-
tively associated with the antibody response, while two
alleles at HLA-DQ locus (DQB1*02:02 and DQA1*01:03)
were positively associated with antibody response. The
12-month follow-up study confirmed that those alleles
associated with positive antibody response were also asso-
ciated with the persistence of this specific antibody
response. Further, we investigated whether HLA class II
polymorphisms would influence the functional proprieties
of DBPII antibodies (BIAbs, binding inhibitory antibodies),
as assessed by the COS-7 cytoadherence assay. The results
demonstrated that four alleles were associated with the
presence (DRB1*07:01; DQB1*02:02, DQA1*02:01) or
absence (DRB1*16:02) of DBPII BIAbs response. Taken
together, this is the first demonstration that HLA class II
polymorphisms might influence the frequency and stability
of the DBPII immune response. Due to the relevance of
these findings for vaccines now in development, it would
be pertinent to investigate whether such an association
exists in other P. vivax malaria endemic areas.
Acknowledgements
Supported by: the Research Foundation of Minas Gerais State (FAPEMIG),
The Brazilian National Research Council (CNPq), Oswaldo Cruz Foundation
(FIOCRUZ/PAPES VI), Laboratório de Imunogenética (UEM/PR).
Authors’ details
1Centro de Pesquisas René Rachou/FIOCRUZ, Belo Horizonte, MG, Brazil.
2Centro de Pesquisas Leonidas e Maria Deane/FIOCRUZ, Manaus, AM, Brazil.
3Universidade Estadual de Maringá, Maringá, Pr, Brazil.
Published: 22 September 2014
doi:10.1186/1475-2875-13-S1-P51
Cite this article as: Kano et al.: Distinct HLA class II alleles influence
antibody response to the Plasmodium vivax Duffy binding protein.
Malaria Journal 2014 13(Suppl 1):P51.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1Centro de Pesquisas René Rachou/FIOCRUZ, Belo Horizonte, MG, Brazil
Full list of author information is available at the end of the article
Kano et al. Malaria Journal 2014, 13(Suppl 1):P51
http://www.malariajournal.com/content/13/S1/P51
© 2014 Kano et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
